SCHEMBL161864

SCHEMBL161864

ClCOc1cc2ccccc2cn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.45
CYP2A6 P11509 1/20 0.45
PDPK1 O15530 1/20 0.45
NPC1 O15118 2/20 0.42
DRD3 P35462 2/20 0.41
KCNH2 Q12809 2/20 0.41
RAB9A P51151 1/20 0.40
PLAU P00749 1/20 0.38
ATM Q13315 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
KDM4E B2RXH2 2/20 0.36
CHEK1 O14757 1/20 0.36
PDE10A Q9Y233 1/20 0.35
CHRNB2 P17787 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA7 P36544 1/20 0.35
CHRNA4 P43681 1/20 0.35
HTR3A P46098 1/20 0.35
AGXT P21549 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13711922 0.80 CYP1A2 (0.45) CYP1A2CYP2A6PDPK1NPC1DRD3
SCHEMBL3372681 0.80 CYP1A2 (0.50) CYP1A2CYP2A6PDPK1NPC1RAB9A
SCHEMBL11883542 0.79 CYP1A2 (0.52) CYP1A2CYP2A6PDPK1NPC1RAB9A
SCHEMBL12250941 0.76 GABRP (0.54) CYP1A2CYP2A6PDPK1NPC1DRD3
SCHEMBL160723 0.75 NPC1 (0.33) CYP1A2NPC1DRD3KCNH2RAB9A
SCHEMBL30746959 0.75 KDM4E (0.57) CYP1A2CYP2A6PDPK1NPC1RAB9A
SCHEMBL6971528 0.75 CYP1A2 (0.48) CYP1A2CYP2A6PDPK1NPC1DRD3
SCHEMBL1536432 0.75 KDM4E (0.57) CYP1A2CYP2A6PDPK1NPC1RAB9A
SCHEMBL14248268 0.74 KDM4E (0.52) CYP1A2CYP2A6PDPK1NPC1RAB9A
SCHEMBL28900602 0.74 DRD3 (0.46) CYP1A2CYP2A6PDPK1NPC1DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025073554-A2 PARP1 INHIBITOR COMPOUNDS Duke Street Bio Limited (GB) 2025-04-10 WO disclosed
EP-2663553-A2 QUINOLINE AND ISOQUINOLINE COMPOUNDS AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2013-11-20 EP disclosed
WO-2012030944-A2 QUINOLINE AND ISOQUINOLINE COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2012-03-08 WO disclosed
EP-2265270-A1 2-AMINOPYRIDINE KINASE INHIBITORS OSI Pharmaceuticals, Inc. (US) 2010-12-29 EP disclosed
WO-2009099982-A1 2-AMINOPYRIDINE KINASE INHIBITORS OSI PHARMACEUTICALS, INC. (US) 2009-08-13 WO disclosed